Myelin Basic Protein and Demyelinating Diseases

References

• Roboz E., Henderson N. Preparation and properties of water soluble proteins from bovine cord with “allergic” activity. Allergic Encephalomyelitis, M. W. Kies, E. C. Alvord, Jr. Charles C. Thomas, Springfield, 111. 1959; 281
   Google Scholar
• Kies M. W., Alvord E. C., Jr. Encephalitogenic activity in guinea pigs of water soluble protein fractions of nervous tissue. Allergic Encephalomyelitis, M. W. Kies, E. C. Alvord, Jr. Charles C. Thomas, Springfield, Ill 1959; 293
   Google Scholar
• Robertson D. M., Blight R., Lumsden C. E. Dialyzable peptide as the causative factor in experimental “allergic” encephalomyelitis. Nature (London) 1962; 196: 1005
   PubMedGoogle Scholar
• Kibler R. F., Fox R. H., Shapira R. Isolation of a highly purified encephalitogenic protein from bovine cord. Nature (London) 1964; 204: 1273
   PubMedGoogle Scholar
• Nakao A., Roboz-Einstein E. Chemical and immunochemical studies with the dialyzable encephalitogenic compound from bovine spinal cord. Ann. N.Y. Acad. Sci. 1965; 122: 171
   PubMedGoogle Scholar
• Nakao A., Davis W. J., Roboz-Einstein E. Basic proteins from the acidic extract of bovine spinal cord. Biochim. Biophys. Acta 1966; 130: 163
   Google Scholar
• Herndon R. M., Johnson M. A method for the electron microscopic study of cerebrospinal fluid sediment. J. Neuropathol. Exp. Neurol. 1970; 29: 320
   PubMedGoogle Scholar
• Baum H. M., Rothchild B. B. The incidence and prevalence of reported multiple sclerosis. Ann. Neurol. 1981; 10: 420
   PubMed Web of Science ®Google Scholar
• Arnason B. G. W. Multiple sclerosis: current concepts and management. Hosp. Pract. 1982; 17(2)81
   Web of Science ®Google Scholar
• McDonald W. I. Multiple sclerosis: the present position. Acta Neurol. Scand. 1983; 68: 65
   PubMedGoogle Scholar
• Broman T., Andersen O., Bergmann L. Clinical studies on multiple sclerosis. I. Presentation of an incidence material from Gothenburg. Acta Neurol. Scand 1981; 63: 6
   PubMedGoogle Scholar
• McFarlin D. E., McFarland H. F. Multiple sclerosis. N. Engl. J. Med. 1982; 307: 1246
   PubMedGoogle Scholar
• Alter M., Kurtzke J. F. The Epidemiology of Multiple Sclerosis. Charles C. Thomas, Springfield, III. 1968
   Google Scholar
• Kurtzke J. F., Beebe G. W., Norman J. E., Jr. Migration and multiple sclerosis in the United States. Neurology 1979; 29: 579
   Google Scholar
• Alter M., Kahana E., Lewenson R. Migration and risk of multiple sclerosis. Neurology 1978; 28: 1089
   PubMed Web of Science ®Google Scholar
• Kurtzke J. F. On the time of onset in multiple sclerosis. Acta Neurol. Scand. 1965; 41: 140
   PubMedGoogle Scholar
• Kurtzke J. F., Hamtoft H. Multiple sclerosis and Hodgkin's disease in Denmark. Acta Neurol. Scand. 1976; 53: 358
   PubMedGoogle Scholar
• Kuwert E. K. Genetical aspects of multiple sclerosis with special regard to histocompatibility determinants. The Histocompatibility System in Multiple Sclerosis. Munksgaard, Copenhagen 1977; 23
   Google Scholar
• McAlpine D., Lumsden G. E., Acheson E. D. Multiple Sclerosis. A Reappraisal, 2nd ed. Williams & Wilkins, Baltimore 1972
   Google Scholar
• Cripps J. R., Ebers G. C. MS evidence for an environmental effect. Neurology 1982; 32(4-II)A164
   PubMedGoogle Scholar
• Alter M., Harshe M., Anderson V. E., Emme L., Yunis E. J. Genetic association of multiple sclerosis and HLA determinants. Neurology 1976; 26: 31
   PubMedGoogle Scholar
• Fog T., Schuller E., Jersild C., Engelfriet C. P., Bertrams J. Neurology. HLA and Disease, J. Dausset, A. Svejgaard. Munksgaard, Copenhagen 1977; 112
   Google Scholar
• Thorsby E., Helgesen A., Solheim B. G., Vandvik B. HLA antigens in multiple sclerosis. J. Neurol. Sci. 1977; 32: 187
   PubMedGoogle Scholar
• Stewart G. J., Basten A., Kirk R. L. Strong linkage disequilibrium between HLA-D2 and BfS in multiple sclerosis and in the normal population. Tissue Antigens 1979; 14: 86
   PubMedGoogle Scholar
• Ebners G. C. Genetic factors in multiple sclerosis. Neurol. Clin. 1983; 1: 645
   PubMedGoogle Scholar
• Adams R. D., Kubik C. S. Symposium on multiple sclerosis and demyelinating diseases; morbid anatomy of demyelinative diseases. Am. J. Med. 1952; 12: 510
   PubMed Web of Science ®Google Scholar
• Lumsden C. E. The clinical pathology of multiple sclerosis. Multiple Sclerosis: A Reappraisal 2nd ed., D. McAlpine, C. E. Lumsden, E. D. Acheson. Churchill Livingstone, Edinburgh 1972; 314
   Google Scholar
• Prineas J. Pathology of the early lesion in multiple sclerosis. Hum. Pathol. 1975; 6: 531
   PubMedGoogle Scholar
• Prineas J. W., Wright R. G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 1978; 38: 409
   PubMed Web of Science ®Google Scholar
• Arnason B. G. W., Fuller T. C., Lehrich J. R., Wray S. H. Histocompatibility types and measles antibodies in multiple sclerosis and optic neuritis. J. Neurol. Sci. 1974; 22: 419
   PubMedGoogle Scholar
• Choppin P. W. Measles virus and chronic neurological diseases. Ann. Neurol. 1981; 9: 17
   PubMedGoogle Scholar
• Johnson R. T. The possible viral etiology of multiple sclerosis. Adv. Neurol. 1975; 13: 1
   PubMedGoogle Scholar
• Johnson R. T. Viral Infections of the Nervous System. Raven Press, New York 1982
   Google Scholar
• Koprowski H. search for the abominable snowman or “deinviren mein viren”. multiple sclerosis, in Siow Virus Infections of the Central Nervous System, V. ter Meulen, M. Katz. Springer-Verlag, New York 1977; 152
   Google Scholar
• ter Muelen V. A case for viral etiology. Slow Virus Infections of the Central Nervous System, V. ter Meulen, M. Katz. Springer-Verlag, New York 1977; 143
   Google Scholar
• Norrby E. Viral antibodies in multiple sclerosis. Prog. Med. Virol. 1978; 24: 1
   PubMedGoogle Scholar
• Bartfeld H., Atoynatan T. In vitro delayed (cellular) hypersensitivity in multiple sclerosis to central nervous system antigens. Int. Arch. Allergy Appl. Immunol. 1970; 39: 361
   PubMedGoogle Scholar
• Lisak R. P., Zwieman B., Waters D., Koprowski H., Pleasure D. E. Cell-mediated immunity to measles, myelin basic protein, and central nervous system extract in multiple sclerosis: a longitudinal study employing direct buffy coat migration inhibition assays. Neurology 1978; 28: 798
   PubMedGoogle Scholar
• Waksman B. H. Current trends in multiple sclerosis research. Immunol. Today 1981; 2(5)87
   PubMedGoogle Scholar
• Weiner H. L., Hauser S. L. Neuroimmunology I: Immunoregulation in neurological disease. Ann. Neurol. 1982; 11: 437
   PubMed Web of Science ®Google Scholar
• Fujinami R. S., Oldstone M. B. A. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985; 230: 1043
   PubMed Web of Science ®Google Scholar
• Marks N., Lajtha A. Protein and polypeptide breakdown. Handbook of Neurochemistry 1971; 5A: 49
   Google Scholar
• Carnegie P. R., Bencina B., Lamoureux G. Experimental allergic encephalomyelitis. Isolation of basic proteins and polypeptides from central nervous tissue. Biochem. J. 1967; 105: 559
   PubMedGoogle Scholar
• Hashim G. A. Myelin basic protein: structure, function, and antigenic determinants. Immunol. Rev. 1978; 39: 60
   PubMed Web of Science ®Google Scholar
• Carnegie P. R., Moore W. J. Myelin basic protein. Proteins of the Nervous System, 2nd ed., R. A. Bradshaw, R. M. Schneider. Raven Press, New York 1980; 229
   Google Scholar
• Braun P. E., Brostoff S. W. Proteins of myelin. Myelin, P. Morell. Plenum Press, New York 1977; 201
   Google Scholar
• Eylar E. H., Thompson M. Allergic encephalomyelitis: the physico-chemical properties of the basic protein encephalitogen from bovine spinal cord. Arch. Biochem. 1969; 129: 468
   PubMedGoogle Scholar
• Deibler G. E., Martenson R. E., Kies M. W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 1972; 2: 139
   PubMed Web of Science ®Google Scholar
• Dunkley P. R., Carnegie P. R. Isolation of myelin basic proteins. Research Methods in Neurochemistry, N. Marks, R. Rodnight. Plenum Press, New York 1974; Vol. 2: 219
   Google Scholar
• Chou F. C.-H., Jen Chou C.-H. J., Shapira R., Kibler R. F. Basis of microheterogeneity of myelin basic protein. J. Biol. Chem. 1976; 251: 2671
   PubMedGoogle Scholar
• Heinemann M. A., Whitaker J. N., Seyer J. M. Separation and isolation of human myelin basic protein peptides by reversed-phase high-performance liquid chromatography in volatile buffers. J. Chromatogr. 1985; 329: 295
   PubMed Web of Science ®Google Scholar
• Tigyi G. J., Balazs L., Monostori E., Ando I. Isolation of human myelin basic protein by immunoaffinity chromatography with a monoclonal antibody. Mol. Immunol. 1984; 21: 889
   PubMed Web of Science ®Google Scholar
• Carnegie P. R. Amino acid sequence of the encephalitogenic basic protein from human myelin. Biochem. J. 1971; 123: 57
   PubMedGoogle Scholar
• Eylar E. H., Brostoff S., Hashim G., Caccam J., Burnett P. Basic Al protein of the myelin membrane. The complete aminoacid sequence. J. Biol. Chem. 1971; 246: 5770
   PubMed Web of Science ®Google Scholar
• Shapira R., McKneally S. S., Chou F., Kibler R. F. Encephalitogenic fragment of myelin basic protein. J. Biol. Chem. 1971; 246: 4630
   Google Scholar
• Eylar E. H., Caccam J., Jackson J. J., Westall F. C., Robinson A. B. Experimental allergic encephalomyelitis: synthesis of disease-inducing site of the basic protein. Science 1970; 168: 1220
   PubMedGoogle Scholar
• Carnegie P. R. Properties, structure, and possible neuroreceptor role of the encephalitogenic protein of human brain. Nature (London) 1971; 229: 25
   PubMedGoogle Scholar
• Shapira R. F., Chou F. C., McKneally S., Urban E., Kibler R. Biological activity and synthesis of an encephalitogenic determinant. Science 1971; 173: 736
   PubMed Web of Science ®Google Scholar
• Hashim G. A., Carvalho E. F., Sharpe R. D. Definition and synthesis of the essential amino acid sequence for experimental allergic encephalomyelitis in Lewis rats. J. Immunol. 1978; 121: 665
   PubMed Web of Science ®Google Scholar
• Karkhanis Y. D., Carlo D. J., Brostoff S. W., Eylar E. M. Allergic encephalomeylitis: isolation of encephalitogenic peptide active in the monkey. J. Biol. Chem. 1975; 250: 1718
   PubMed Web of Science ®Google Scholar
• Gibson B. W., Gilliom R. D., Whitaker J. N., Biemann K. Amino acid sequence of human myelin basic protein peptide 45–89 as determined by mass spectrometry. J. Biol. Chem. 1984; 259: 5028
   PubMedGoogle Scholar
• Driscoll B. F., Kramer A. J., Kies M. W. Myelin basic protein: location of multiple independent antigenic regions. Science 1974; 184: 73
   PubMedGoogle Scholar
• Wallace A. D., Shapira R., Fritz R. B. Isolation and characterization of rabbit antibodies to bovine myelin basic protein. Immunochemistry 1978; 15: 47
   PubMedGoogle Scholar
• Brostoff S. W., Reuter W., Hichens M., Eylar E. H. Specific cleavage of the Al protein from myelin with cathepsin D. J. Biol. Chem. 1974; 249: 559
   PubMedGoogle Scholar
• Martenson R. E., Luthy V., Deibler G. E. Cleavage of rabbit myelin basic protein by pepsin. J. Neurochem. 1981; 36: 58
   PubMedGoogle Scholar
• Whitaker J. N., Chou C.-H. J., Chou F C.-H., Kibler R. F. Antigenic determinants of bovine myelin encephalitogenic protein recognized by rabbit antibody to myelin encephalitogenic protein. J. Biol. Chem. 1975; 250: 9106
   PubMedGoogle Scholar
• Whitaker J. N., Bashir R. M., Chou C.-H. J., Kibler R. F. Antigenic features of myelin basic protein like material in CSF. J. Immunol. 1980; 124: 1148
   PubMedGoogle Scholar
• Whitaker J. N. The appearance of a new antigenic determinant during the degradation of myelin basic protein. J. Neuroimmunol. 1982; 2: 201
   PubMedGoogle Scholar
• Fritz R. B., Chou C.-H. J. Epitopes of peptide 43–88 of guinea pig myelin basic protein: localization with monoclonal antibodies. J. Immunol. 1983; 130: 2180
   PubMedGoogle Scholar
• Chou C. H., Chou F. C., Kowalski T. J., Shapira R., Kibler R. F. The major site of guinea pig myelin basic protein encephalitogenic in Lewis rats. J. Neurochem. 1977; 28: 115
   PubMed Web of Science ®Google Scholar
• Kibler R. F., Re P. K., McKneally S., Shapira R., Keeling M. E. Biological activity of encephalitogenic fragment in the monkey. J. Biol. Chem. 1972; 247: 969
   PubMedGoogle Scholar
• Hershey L. A., Gado M. H., Trotter J. L. Computerized tomography in the diagnostic evaluation of multiple sclerosis. Ann. Neurol. 1979; 5: 32
   PubMedGoogle Scholar
• Young I. R., Hall A. S., Pallis C. A., Legg N. J., Bydder G. M., Sterner R. E. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2: 1063
   PubMed Web of Science ®Google Scholar
• Lukes S. A., Crooks L. E., Aminoff M. J., Kaufman L., Panitch H. S., Mills C., Norman D. Nuclear magnetic resonance imaging in multiple sclerosis. Ann. Neurol. 1983; 13: 592
   PubMed Web of Science ®Google Scholar
• Drayer B. P., Barrett L. Magnetic resonance imaging and CT scanning in multiple sclerosis. Ann. N.Y. Acad. Set 1984; 436: 294
   PubMedGoogle Scholar
• Brooks E. B., Chiappa K. H. A comparison of clinical neuro ophthalmological findings and pattern shift visual evoked potentials in multiple sclerosis. Clinical Applications of Evoked Potentials in Neurology, J. J. Courjon, F. Mauguiere, M. Revol. Raven Press, New York 1982; 435
   Google Scholar
• Chiappa K. H. Pattern-shift visual, brainstem auditory and short-latency somatosensory evoked potentials in multiple sclerosis. Ann. N. Y. Acad. Sci. 1984; 436: 315
   PubMedGoogle Scholar
• Kabat E. A., Freedman D. A., Murray J. P., Knaub V. Study of crystalline albumin, gamma globulin, and total protein in the cerebrospinal fluid of 100 cases of multiple sclerosis and in other diseases. Am. J. Med. Sci. 1950; 219: 55
   PubMed Web of Science ®Google Scholar
• Tourtellotte W. W. On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases: a review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system. J. Neurol. Sci. 1970; 10: 279
   PubMed Web of Science ®Google Scholar
• Walsh M. J., Tourtellotte W. W. The cerebrospinal fluid in multiple sclerosis. Multiple Sclerosis, J. F. Hallpike, C. W. M. Adams, W. W. Tourtellotte. Williams & Wilkins, Baltimore 1983; 275
   Google Scholar
• Link H., Tibbling G. Principles of albumin and IgG analysis in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid. Scand. J. Clin. Lab. Invest. 1977; 37: 391
   PubMed Web of Science ®Google Scholar
• Tourtellotte W. W., Ma B. I. Multiple sclerosis: the blood-brain-barrier and the measurement of de novo central nervous system IgG synthesis. Neurology 1978; 28(9-II)76
   PubMedGoogle Scholar
• Tourtellotte W. W., Potvin A. R., Fleming J. O., Murthy K. N., Levy J., Syndulko K., Potvin J. H. Multiple sclerosis: measurement and validation of central nervous system IgG synthesis rate. Neurology 1980; 30: 240
   PubMed Web of Science ®Google Scholar
• Mandler R., Goren H., Valenzuela R. Value of central nervous system IgG daily synthesis determination in the diagnosis of multiple sclerosis. Neurology 1982; 32: 296
   PubMedGoogle Scholar
• Hershey L. A., Trotter J. L. The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation. Ann. Neurol. 1980; 8: 426
   PubMedGoogle Scholar
• Johnson K. P. Cerebrospinal fluid and blood assays of diagnostic usefulness in multiple sclerosis. Neurology 1980; 30(7-II)106
   PubMedGoogle Scholar
• Chu A. B., Sever J. L., Madden D. L., Iwanainen M., Leon M., Wallen W., Brooks B. R., Lee Y. J., Houff S. Oligoclonal IgG bands in cerebrospinal fluid in various neurological diseases. Ann. Neurol. 1983; 13: 434
   PubMed Web of Science ®Google Scholar
• Miller J. R., Burke A. M., Bever C. T. Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases. Ann. Neurol. 1983; 13: 53
   PubMed Web of Science ®Google Scholar
• Paterson P. Y., Whitacre C. C. The enigma of oligoclonal immunoglobulin G in cerebrospinal fluid from multiple sclerosis patients. Immunol. Today 1981; 2: 111
   PubMedGoogle Scholar
• McPherson T. A., Marchalonis J. J., Lennon V. Binding of encephalitogenic basic protein by serum alpha-globulins. Immunology 1970; 19: 929
   PubMedGoogle Scholar
• McPherson T. A., Gilpin A., Seland T. P. Radioimmunoassay of CSF for encephalitogenic basic protein: a diagnostic test for MS?. Can. Med. Assoc. J. 1972; 107: 856
   PubMedGoogle Scholar
• Schmid G., Thomas G., Hempel K., Grüninger W. Radioimmunological determination of myelin basic protein (MBP) and MBP-antibodies. Eur. Neurol. 1974; 12: 173
   PubMedGoogle Scholar
• Day E. D., Pitts O. M. Radioimmunoassay of myelin basic protein in sodium sulfate. Immunochemistry 1974; 11: 651
   PubMedGoogle Scholar
• Cohen S. R., McKhann G. M., Guarnieri M. A radioimmunoassay for myelin basic protein and its use for quantitative measurements. J. Neurochem. 1975; 25: 371
   PubMedGoogle Scholar
• Palfreyman J. W., Thomas D. G., Ratcliffe J. G. Radioimmunoassay for human myelin basic protein in biological fluids and tissue extract. Biochem. Soc. Trans. 1977; 5: 1422
   PubMedGoogle Scholar
• Hsiung H. M., Wu J., McPherson T. A. Silica gel radioimmunoassay for myelin basic protein. Clin. Biochem. 1978; 11: 54
   PubMedGoogle Scholar
• Whitaker J. N. Myelin encephalitogenic protein fragments in cerebrospinal fluid of persons with multiple sclerosis. Neurology 1977; 27: 911
   PubMed Web of Science ®Google Scholar
• Palfreyman J. W., Thomas D. G., Ratcliff J. G. Radioimmunoassay of human myelin basic protein in tissue extract, cerebrospinal fluid and serum and its clinical application to patients with head injury. Clin. Chim. Acta 1982; 82: 259
   Google Scholar
• Ohta M., Matsubara F., Konishi T., Nishitani H. Radioimmunoassay of myelin basic protein in cerebrospinal fluid and its clinical application to patients with neurological diseases. Life Sci. 1980; 27: 1069
   PubMedGoogle Scholar
• Delassalle A., Jacque C., Drouet J., Raoul M., Legrand J. C., Cesselin F. Radioimmunoassay of myelin basic protein in biological fluids, conditions improving sensitivity and specificity. Biochemie 1980; 62: 159
   PubMedGoogle Scholar
• Biber A., Englert D., Dommasch D., Hempel K. Myelin basic protein in cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. J. Neurol. 1981; 225: 231
   PubMedGoogle Scholar
• Karlsson B., Ailing C. Radioimmunoassay of myelin basic protein. A methodological evaluation. J. Immunol. Methods 1982; 55: 51
   PubMedGoogle Scholar
• Dowse C. A., Carnegie P. R., Linthicum D. S., Bernard C. C. Solid phase radioimmunoassay for human basic protein using a monoclonal antibody. J. Neuroimmunol. 1983; 5: 135
   PubMedGoogle Scholar
• Groome N. P. Enzyme-linked immunoadsorbent assays for myelin basic protein and antibodies to myelin basic protein. J. Neurochem. 1980; 35: 1409
   PubMed Web of Science ®Google Scholar
• Groome N. P. Plasma myelin basic protein assay using Gilford enzyme immunoassay cuvettes. J. Clin. Chem. Clin. Biochem. 1981; 19: 1067
   PubMedGoogle Scholar
• Shinomiya Y., Kato N., Imazawa M., Miyamoto K. Enzyme immunoassay of the myelin basic protein. J. Neurochem. 1982; 39: 1291
   PubMedGoogle Scholar
• Spatz L., Whitman L., Messito M. J., Nilaver G., Ginsberg S., Latov N. Measurement of myelin basic protein and of anti-basic protein antibodies by ELISA utilizing biotinylated antibodies. Immunol. Commun. 1983; 12: 31
   PubMed Web of Science ®Google Scholar
• Sires L. R., Hruby S., Alvord E. C., Jr., Hellstrom I., Hellström K E., Kies M. W., Martenson R., Deibler G. E., Beckman E. D., Casnellie J. E. Species restrictions of a monoclonal antibody reacting with residues 130 to 137 in encephalitogenic myelin basic protein. Science 1981; 214: 87
   PubMedGoogle Scholar
• Gupta M. K., Goren H., Johnson C., Bocci L., Valenzuela R. Myelin basic protein (MBP) quantitation in CSF of patients with MS and its relationship with disease activity. Neurology 1984; 34(Suppl. 1)78, 12
   PubMedGoogle Scholar
• Whitaker J. N., Gupta M. Epitopes of myelin basic protein in human cerebrospinal fluid. Trans. Am. Soc. Neurochem. 1985; 16: 415
   Google Scholar
• Day E. D., Hashim G. A., Varitek V. A., Jr., Paterson P. Y. Immunogenicity of synthetic peptide sequences S81 and S82 (residues 68–83 and 65–83) of bovine myelin basic protein. Time course of antibody responses in rats and rabbits. J. Neuroimmunol. 1981; 1: 205
   PubMedGoogle Scholar
• Whitaker J. N. The antigenic reactivity of small fragments derived from human myelin basic protein peptide 43–88. Immunology 1982; 129: 2729
   Google Scholar
• Day E. D., Vartiek V. A. Radioimmunoassay of antibodies in myelin basic protein, dual-dilution radioimmunoassays, and competitive binding radioimmunoassays to measure myelin basic protein and its fragments. Manual of Clinical Immunology 2nd ed., N. R. Rose, H. Friedman. American Society for Microbiology, Washington, D.C. 1980; 380
   Google Scholar
• Day E. D., Hashim G. A., Varitek V. A., Jr., Paterson P. Y. Equilibrium competitve inhibition analysis of synthetic peptide antigens from myelin basic protein as affected by the dual-dilution phenomenon. J. Neuroimmunol. 1981; 1: 217
   PubMedGoogle Scholar
• Hunter W. M. Radioimmunoassay. Handbook of Experimental Immunology, D. M. Weir. Blackwell Scientific, Oxford 1973; 14.1
   Google Scholar
• Lamoureux G., Carnegie P. R., McPherson T. A., Johnston D. Experimental allergic encephalomyelitis: immunological properties of encephalitogenic polypeptides and proteins. Clin. Exp. Immunol. 1967; 2: 601
   PubMedGoogle Scholar
• Jones A. J., Rumbsy M. G. The intrinsic fluorescence characteristics of the myelin basic protein. J. Neurochem. 1975; 25: 565
   PubMedGoogle Scholar
• Tanaka K., Orth D. N. The detection of “purified” incubation damage by several radioimmunoassay separation methods. J. Lab. Clin. Med. 1978; 91: 881
   PubMedGoogle Scholar
• Nagelkerken L. M., Van Zoonen-Van Exel M., Aalberse R. C., Van Walbeek H. K., Out T. A. Comparison of a non-competitive two-site RIA and an inhibition RIA for the detection of myelin basic protein in cerebrospinal fluid. J. Neuroimmunol. 1983; 5: 157
   PubMedGoogle Scholar
• Dowse C. A., Carnegie P. R., Linthicum D. S., Bernard C. C. Solid phase radioimmunoassay for human myelin basic protein using a monoclonal antibody. J. Neuroimmunol. 1983; 5: 135
   PubMedGoogle Scholar
• Cohen S. R., Brune M. J., Herndon R. M., McKhann G. M. Cerebrospinal fluid myelin basic protein and multiple sclerosis. Adv. Exp. Med. Biol. 1978; 100: 513
   PubMedGoogle Scholar
• Carson J. H., Barbarese E., Braun P. E., McPherson T. A. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein. Proc. Natl. Acad. Sci. U.S.A. 1978; 75: 1976
   PubMedGoogle Scholar
• Bashir R. M., Whitaker J. N. Molecular features of immunoreactive myelin basic protein in cerebrospinal fluid of persons with multiple sclerosis. Ann. Neurol. 1980; 7: 50
   PubMedGoogle Scholar
• Groome N., Harland J., Dawkes A. Preparation and properties of monoclonal antibodies to myelin basic protein and its peptides. Neurochem. Int. 1985; 7: 309
   PubMedGoogle Scholar
• Cohen S. R., Herndon R. M., McKhann G. M. Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination. N. Engl. J. Med. 1976; 295: 1455
   PubMed Web of Science ®Google Scholar
• Cohen S. R., Brooks B. R., Herndon R. M., McKhann G. M. A diagnostic index of active demyelination: myelin basic protein in cerebrospinal fluid. Ann. Neurol. 1980; 8: 25
   PubMed Web of Science ®Google Scholar
• Whitaker J. N., Lisak R. P., Bashir R. M., Fitch O. H., Seyer J. M., Krance R., Lawrence J. A., Chien L. T., O'Sullivan P. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders. Ann. Neurol. 1980; 7: 58
   PubMed Web of Science ®Google Scholar
• Thomas D. G. T., Palfreyman J. W., Ratcliffe J. G. Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury. Lancet 1978; 1: 113
   PubMed Web of Science ®Google Scholar
• Gangji D., Reaman G. H., Cohen S. R., Bleyer W. A., Poplack D. G. Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia. N. Engl. J. Med. 1980; 303: 19
   PubMedGoogle Scholar
• Ohta M., Nishitani H., Matsubara F., Inaba G. Myelin basic protein in spinal fluid from patients with neuro-Behcet's disease Getter). N. Engl. J. Med. 1980; 302: 1093
   PubMedGoogle Scholar
• Jacque C., Delassalle A., Rancurel G., Raoul M., Lesourd B., Legrand J.-C. Myelin basic protein in CSF and blood. Relationship between its presence and the occurrence of a destructive process in the brains of encephalitic patients. Arch. Neurol. 1982; 39: 557
   PubMedGoogle Scholar
• Ailing C., Karlsson B., Vällfors B. Increase in myelin basic protein in CSF after brain surgery. J. Neurol. 1980; 223: 225
   PubMedGoogle Scholar
• Sutton L. N., Wood J. H., Brooks B. R., Barrer S. J., Kline M., Cohen S. R. Cerebrospinal fluid myelin basic protein in hydrocephalus. J. Neurogsurg. 1983; 59: 467
   PubMed Web of Science ®Google Scholar
• Gerson B., Cohen S. R., Gerson I. M., Guest G. H. Myelin basic protein, oligoclonal bands, and IgG in cerebrospinal fluid as indicators of multiple sclerosis. Clin. Chem. 1974; 27: 1981
   Google Scholar
• Pescovitz M. D., Paterson P. Y., Kelly J., Lorand L. Serum degradation of myelin basic protein with loss of encephalitogenic activity: evidence of an enzymatic process. Ceil. Immunol. 1978; 39: 355
   PubMedGoogle Scholar
• Lennon V., Mackay I. R. Binding of 125I myelin basic protein by serum and cerebrospinal fluid. Clin. Exp. Immunol 1972; 11: 595
   PubMedGoogle Scholar
• Bernard C. C., Lamoureux G. Inhibition by serum of encephalitogenic activity of myelin basic protein. Int. Arch. Allergy Appl. Jmmunoi. 1975; 48: 597
   PubMedGoogle Scholar
• Macklin W. B., Lees M. B., Cohen S. R., Ayella S. B. Hydrophobic compounds interfere in radioimmunoassay for basic protein in myelin. Clin. Chem. 1981; 27: 742
   PubMedGoogle Scholar
• Whitaker J. N., Heinemann M. A., Smith O. F. Displacement and degradation of radioligand in radioimmunoassay of myelin basic protein peptides. Neurology 1982; 32: A86
   Google Scholar
• Johnson A. B., Cammer W. Commercial horseradish peroxidase degrades myelin encephalitogenic protein during coupling for immunohistochemical studies. J. Histochem. Cytochem. 1977; 25: 329
   PubMedGoogle Scholar
• Alvord E. C., Kies N. W., Suckling A. J. Experimental allergic encephalomyelitis: a useful model for multiple sclerosis. Prog. Clin. Biol. Res. 1984; 146: 1
   PubMedGoogle Scholar
• Alvord E. C. Acute disseminated encephalomyelitis and “allergic” Neuro-encephalopathies. Handbook of Clinical Neurology, P. J. Viken, G. W. Bruyn. Elsevier, New York 1979; Vol. 9: 500
   Google Scholar
• Keis M. W., Murphy J. B., Alvord E. C. Fractionation of guinea pig brain proteins with encephalitogenic activity. Fed. Proc. 1960; 19: 207
   Google Scholar
• Lampert P. W., Kies M. W. Mechanism of demyelination in allergic encephalomyelitis of guinea pigs. An electron microscopic study. Exp. Neurol. 1967; 18: 210
   PubMedGoogle Scholar
• Wisniewski H. M., Keith A. B. Chronic relapsing experimental allergic encephalomyelitis: an experimental model of multiple sclerosis. Ann. Neurol 1977; 1: 144
   PubMed Web of Science ®Google Scholar
• Lassmann H. Chronic relapsing experimental allergic encephalomyelitis: its value as an experimental model for multiple sclerosis. J. Neurol 1983; 299: 207
   Google Scholar
• Lassmann H., Wisniewski H. M. Chronic relapsing experimental allergic encephalomyelitis: clinicopathological comparison with multiple sclerosis. Arch. Neurol 1979; 36: 490
   PubMedGoogle Scholar
• Edgington T. S., Dalessio D. J. The assessment by immunoflourescence methods of humoral anti-myelin antibodies in man. J. Immunol 1970; 105: 248
   PubMedGoogle Scholar
• Lisak R. P., Zwiman B., Norman M. Antimyelin antibodies in neurologic diseases: immunofluorescent demonstration. Arch. Neurol 1975; 32: 163
   PubMedGoogle Scholar
• Ryberg B. Complement-fixing antibrain antibodies in multiple sclerosis: comparison of their occurrence in cerebrospinal fluid and serum. Acta Neurol. Scand. 1976; 54: 1
   PubMedGoogle Scholar
• Aarli J. A., Aparicio S. R., Lumsden C. E., Tonder O. Binding of normal human IgG to myelin sheaths, glia, and neurons. Immunology 1975; 28: 171
   PubMed Web of Science ®Google Scholar
• Abramsky O., Lisak R. P., Silberg D. H., Pleasure D. E. Antibodies to oligodendroglia in patients with multiple sclerosis. N. Engl. J. Med. 1977; 297: 1207
   PubMed Web of Science ®Google Scholar
• Traugott U., Synder S., Raine C. S. Oligodendrocyte staining by multiple sclerosis serum is nonspecific. Ann. Neurol. 1979; 6: 13
   PubMedGoogle Scholar
• Randolph D. H., Kibler R. F., Fritz R. B. Solid-phase radioimmunoassay for detection of antibodies to myelin basic protein. J. Immunol Methods 1977; 18: 215
   PubMedGoogle Scholar
• Panitch H. S., Hafler D. A., Johnson K. P. Antibodies to myelin basic protein in multiple sclerosis: clinical correlations. Neurology 1978; 28: 394
   Google Scholar
• Biggins J. A., Taylor A., Caspary E. A. Circulating antibody to myelin basic protein in relapsing-remitting multiple sclerosis? A comparative group and sequential study by radioimmunoassay. J. Neurol Neurosurg. Psych. 1978; 41: 1131
   PubMedGoogle Scholar
• Gutstein H. S., Cohen S. R. Spinal fluid differences in experimental allergic encephalomyelitis and multiple sclerosis. Science 1978; 199: 301
   PubMed Web of Science ®Google Scholar
• Panitch H. S., Hooper C. J., Johnson K. P. CSF antibody to myelin basic protein: measurements in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch. Neurol 1980; 37: 206
   PubMedGoogle Scholar
• Ruutiainen J., Arnadottir T., Molnar G., Salmi A., Frey H. Myelin basic protein antibodies in the serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis patients. Acta Neurol. Scand. 1981; 64: 196
   PubMed Web of Science ®Google Scholar
• Linthicum D. S., Jones S., Horvath L., Carnegie P. R. Detection of antibodies to myelin basic protein by solid-phase radioimmunoassay with 126I protein A. J. Neuroimmunol. 1981; 1: 17
   PubMedGoogle Scholar
• Paterson P. Y., Day E. D., Whitacre C. C., Berenberg R. A., Harter D. H. Endogenous myelin basic protein-serum factors (MBP-SFs) and anti-MBP antibodies in humans: occurrence in sera of clinically well subjects and patients with multiple sclerosis. J. Neurol. Sci. 1981; 52: 37
   PubMedGoogle Scholar
• Wajgt A., Gorny M. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies. Acta Neurol Scand. 1983; 68: 337
   PubMed Web of Science ®Google Scholar
• Gorny M. K., Wroblewska Z., Pleasure D., Miller S. L., Wajgt A., Koprowski H. CSF antibodies to myelin basic protein and oligodendrocytes in multiple sclerosis and other neurological diseases. Acta Neurol. Scand. 1983; 67: 338
   PubMedGoogle Scholar
• Rabinowitz S. G., Day E. D., Paterson P. Y., Koenig H. Endogenous myelin basic protein-serum factors (MBP-SFS) and anti-MBP antibodies in a patient with post-herpes simplex virus acute disseminated encephalomyelitis. J. Neurol. Sci. 1983; 60: 393
   PubMedGoogle Scholar
• Chou C.-H. J., Tourtellotte W. W., Kibler R. F. Failure to detect antibodies to myelin basic protein or peptic fragments of myelin basic protein in CSF of patients with MS. Neurology 1983; 33: 24
   PubMedGoogle Scholar
• Page N., Perruisseau G., Steck A. J. Binding properties of cerebrospinal fluid IgG in multiple sclerosis and other neurological diseases. J. Neurol. Sci. 1983; 60: 23
   PubMedGoogle Scholar
• Hruby S., Sires L. R., Alvord E. C., Jr. An ELISA method for the determination of myelin basic protein and its antibodies. Clin. Chem. 1982; 28: 1596
   Google Scholar
• Akiyama K. Highly sensitive-beta-D-galactosidase-linked immunosorbent assay for anti-myelin basic protein antibody. J. Exp. Med. 1983; 53: 181
   Google Scholar
• Herbrink P., van Lambalgen R., Sanders E. A. C. M. Antibodies to myelin basic protein in multiple sclerosis (letter). Neurology 1985; 35: 139
   PubMedGoogle Scholar
• Sindic C. J. M., Cambiaso C. L., Masson P. L., Laterre E. C. The binding of myelin basic protein to the Fc region of aggregated IgG and to immune complexes. Clin. Exp. Immunol. 1980; 41: 1
   PubMedGoogle Scholar
• Day E. D. Radioimmunoassay for myelin basic protein. Clin. Immunol. Newslett. 1982; 3: 53
   Google Scholar
• W.H.O. The role of immune complexes in disease, World Health Organization. Tech. Rep. 1977, Ser. 606, Geneva
   Google Scholar
• Cochrane C. G., Dixon F. J. Immune complex injury. Immunological Diseases, M. Santer. Little Brown, Boston 1977
   Google Scholar
• Zubler R. H., Lambert P. H. in Clinical Immunology, R. A. Thompson. Churchill Livingstone, Edinburgh 1977; 125
   Google Scholar
• Zubler R. H., Nydegger U. E., Lambert P. H., Miescher P. A. Clinical and pathophysiological relevance of the detection of immune complexes in rheumatoid arthritis. Non-articular Forms of Rheumatoid Arthritis, T. E. W. Feltkamp. Stafleu's Scientific, Leyden 1977; 29
   Google Scholar
• Theofilopoulos A. N., Eisenberg R. A., Dixon F. J. Isolation of circulating immune complexes using Raji cells: separation of antigens from immune complexes and production of antiserum. J. Clin. Invest. 1978; 61: 1570
   PubMedGoogle Scholar
• Woyciechowska J. L., Brzosko W. J. Immunoflorescence study of brain plaques from two patients with multiple sclerosis. Neurology 1977; 27: 620
   PubMedGoogle Scholar
• Theofilopoulos A. N., Dixon F. J. Immune complexes in human sera detected by the Raji cell radioimmune assay. In Vitro Methods in Cell Mediated and Tumor Immunity, B. R. Bloom, J. R. David. Academic Press, New York 1976; 555
   Google Scholar
• Zubler R. H., Lambert P. H. The 125I-Clq binding test for the detection of soluble immune complexes. In Vitro Methods in Cell Mediated and Tumor Immunity, B. R. Bloom, J. R. David. Academic Press, New York 1976; 565
   Google Scholar
• Johny K. V., Dasgupta M. K., Singh B., Dossetor J. B. Radioconglutinin-binding assay for circulating immune complexes: new method. Clin. Exp. Immunol. 1980; 40: 459
   PubMedGoogle Scholar
• Tachovsky T. G., Lisak R. P., Koprowski H., Theofilopoulos A. N., Dixon F. J. Circulating immune complexes in multiple sclerosis and other neurological diseases. Lancet 1976; 2: 997
   PubMed Web of Science ®Google Scholar
• Jacque C., Davous P., Baumann N. Circulating immune complexes and multiple sclerosis. Lancet 1977; 2: 408
   PubMedGoogle Scholar
• Goust J. M., Chenais F., Carnes J. E., Hames C. G., Fundenberg H. H., Hogan E. L. Abnormal T cell subpopulations and circulating immune complexes in the Guillian-Barre syndrome and multiple sclerosis. Neurology 1978; 28: 421
   PubMedGoogle Scholar
• Deicher H., Schwabedissn H. M., Liman W., Baruth B., Patzold U., Haller P. Immune complexes in cerebrospinal fluid and serum of patients with multiple sclerosis. Progress in Multiple Sclerosis Research, H. G. Brauer, S. Poser, G. Ritter. Springer-Verlag, Berlin 1980; 200
   Google Scholar
• Trouillas P., Vincent C., Revillard J. V. Clq binding circulating immune complexes in multiple sclerosis patients and their first-degree relatives: a distinctive immunological feature between sporadic and familial cases. J. Clin. Lab. Immunol. 1980; 4: 77
   PubMedGoogle Scholar
• Noronha A. B. C., Antel J. P., Roos R. P., Medof M. E. Circulating immune complexes in neurologic disease. Neurology 1981; 31: 1402
   PubMedGoogle Scholar
• Dasgupta M. K., Warren K. G., Johny K. V., Dossetor J. B. Circulating immune complexes in multiple sclerosis: relation with disease activity. Neurology 1982; 32: 1000
   PubMedGoogle Scholar
• Schocket A. L., Carr R. I., Hardtke M. A. A comaprison of 125I Clq binding, Raji cell binding and lymphocytotoxic activity in multiple sclerosis. Clin. Immunol. Immunopathol. 1980; 17: 477
   PubMedGoogle Scholar
• Jans H., Jersild C., Taaning E., Dybkjaer E., Fog T., Heltberg A. The occurrence of immune complexes in patients with multiple sclerosis. Progress in Multiple Sclerosis Research, H. G. Brauer, S. Poser, G. Ritter. Springer-Verlag, Berlin 1980; 195
   Google Scholar
• Dasgupta M. K., Catz I., Warren K. G., McPherson T. A., Dossetor J. B., Carnegie P. R. Myelin basic protein: a component of circulating immune complexes in multiple sclerosis. Can. J. Neurol. Sci. 1983; 10: 239
   PubMedGoogle Scholar
• Paterson P. Y., Day E. D. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis. Clin. Immunol. Rev. 1982; 1: 581
   Google Scholar
• Lisak R. P. Multiple sclerosis: evidence for immunopathogenesis. Neurology 1980; 30(2)99
   PubMedGoogle Scholar
• Iivanainen M. V. The significance of abnormal immune responses in patients with multiple sclerosis. J. Neuroimmunol. 1981; 1: 141
   PubMedGoogle Scholar
• Källen B., Nilsson O., Thelin C. Effect of encephalitogenic protein on migration in agarose of leukocytes from patients with multiple sclerosis: variable effect of the antigen in a large dose range. Acta Neurol. Scand. 1976; 55: 33
   Google Scholar
• Lisak R. P., Zweiman B., Waters D., Koprowski H., Pleasure D. E. Cell-mediated immunity to measles, myelin basic protein, and central nervous system extract in multiple sclerosis; a longitudinal study employing direct buffy coat migration inhibition assays. Neurology 1978; 28: 798
   PubMedGoogle Scholar
• Youngchaiyud U., Coates A. S., Whittingham S., Mackay I. R. Cellular immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidents. Aust. N. Z. J. Med. 1974; 4: 535
   PubMedGoogle Scholar
• Offner H., Konat G., Raun N. E., Clausen J. E rosette-forming lymphocytes in multiple sclerosis patients. Basic protein stimulation of rosette-forming cells. Acta Neurol. Scand. 1978; 57: 380
   PubMedGoogle Scholar
• Hughes R. A. C., Gray I. A., Clifford-Jones R., Stern M. A. Lymphocyte transformation in the presence of myelin basic protein in multiple sclerosis and control subjects. Acta Neurol. Scand. 1979; 60: 65
   PubMedGoogle Scholar
• Johnson R. T., Griffin D. E., Hirsch R. I., Wolinsky J. S., Roedenbeck S., de Soriano I L., Vasberg A. Measels encephalomyelitis - clinical and immunologic studies. N. Engl. J. Med. 1984; 310: 137
   PubMed Web of Science ®Google Scholar
• Reinherz E. L., Weiner H. L., Hauser S. L., Cohen J. A., Distaso J. A., Schlossman S. F. Loss of suppressor T-cells in active multiple sclerosis. N. Engl. J. Med. 1980; 303: 125
   PubMed Web of Science ®Google Scholar
• Bach M. A., Martin C., Cesaro P., Eizenbaum J. F., Degos J. D. T-cell subsets in multiple sclerosis. A longitudinal study of exacerbating-remitting cases. J. Neuroimmunol. 1985; 7: 331
   PubMedGoogle Scholar
• Paty D. W., Kastrukoff L. F. Suppressor T cells in MS: do changes in numbers vary with clinical activity?. Ann. N.Y. Acad. Sci. 1984; 436: 266
   PubMedGoogle Scholar
• Antel J. P., Peeples D. M., Reder A. T., Arnason B. G. Analysis of T regulator cell surface markers and functional properties in multiple sclerosis. J. Neuroimmunol. 1984; 6: 93
   PubMedGoogle Scholar
• Antel J. P., Arnason B. G. W., Medof M. E. Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann. Neurol. 1979; 5: 338
   PubMed Web of Science ®Google Scholar
• Santoli D., Moretta L., Lisak R., Gilden D., Koprowski H. Imbalances in T cell subpopu-lations in multiple sclerosis patients. J. Immunol. 1978; 120: 1369
   PubMedGoogle Scholar